Skip to main content
Screener/Healthcare/Medical - Instruments & Supplies

RGEN — Repligen Corporation

NASDAQ
$139.16+12.75 (+10.09%)
Mid CapHealthcare
$100.99
$175.77
$127.17
$139.87
EPS (TTM)$0.90
P/E Ratio139.97
Dividend Yield—
Market Cap$7.53B
Volume850K
Prev Close$126.37
Revenue & Operating Income
Revenue
Operating Income
Net Income
Positive
Negative
Free Cash Flow
Positive
Negative
Gross Profit & Operating Expenses
Gross Profit
Operating Expenses
Earnings Per Share
Positive
Negative
Balance Sheet
Total Assets
Total Liabilities
Cash & Equivalents
Cash & Equivalents
Shares Outstanding
Shares Outstanding
Margins
Gross Margin
Operating Margin
Net Margin

Quarterly Results

QuarterRevenueNet IncomeEPSGross MarginNet Margin
Q1 '26$194.3M$8.3M$0.1555.7%4.3%
Q4 '25$197.9M$13.3M$0.2347.2%6.7%
Q3 '25$188.8M$14.9M$0.2653.2%7.9%
Q2 '25$182.4M$14.9M$0.2650.0%8.2%
Q1 '25$169.2M$5.8M$0.1053.6%3.4%
Q4 '24$167.5M-$33.9M$-0.6023.2%-20.2%
Q3 '24$154.9M-$654K$0.3250.0%-0.4%
Q2 '24$158.8M$5.7M$0.0646.2%3.6%
Get Your Daily Market Recap